series-a
Stage
1
Investors
About
Dxcover develops a multi-omic liquid biopsy platform using machine learning and spectral analysis for early detection of multiple high-mortality cancers including brain, pancreatic, and ovarian cancers.
Explore Dxcover's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.